Page 155 - Orange Book Cumulative Supplement 10 October 2012
P. 155
A - 18
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content
PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
EXENATIDE SYNTHETIC - BYETTA
N021773 002 M-113 Oct 19, 2014
M-111 Oct 19, 2014
EZETIMIBE - ZETIA
N021445 001 M-109 Jan 24, 2015
EZETIMIBE; SIMVASTATIN - VYTORIN
N021687 001 M-109 Jan 24, 2015
EZETIMIBE; SIMVASTATIN - VYTORIN
N021687 002 M-109 Jan 24, 2015
EZETIMIBE; SIMVASTATIN - VYTORIN
N021687 003 M-109 Jan 24, 2015
EZETIMIBE; SIMVASTATIN - VYTORIN
N021687 004 M-109 Jan 24, 2015
FAMCICLOVIR - FAMVIR
N020363 001 M-112 Feb 09, 2015
FAMCICLOVIR - FAMVIR
N020363 002 M-112 Feb 09, 2015
FAMCICLOVIR - FAMVIR
N020363 003 M-112 Feb 09, 2015
FAMOTIDINE; IBUPROFEN - DUEXIS
N022519 001 >A> 8309127 Jul 18, 2026 DP
FENOFIBRATE - FENOGLIDE
N022118 001 8124125 Oct 01, 2024 DP U-1234
FENOFIBRATE - FENOGLIDE
N022118 002 8124125 Oct 01, 2024 DP U-1234
FENTANYL - SUBSYS
N202788 001 NP Jan 04, 2015
FENTANYL - SUBSYS
N202788 002 NP Jan 04, 2015
FENTANYL - SUBSYS
N202788 003 NP Jan 04, 2015
FENTANYL - SUBSYS
N202788 004 NP Jan 04, 2015
FENTANYL - SUBSYS
N202788 005 NP Jan 04, 2015
FENTANYL CITRATE - FENTORA
N021947 001 8092832 Dec 30, 2024 DP
FENTANYL CITRATE - FENTORA
N021947 002 8092832 Dec 30, 2024 DP
8119158 Dec 30, 2024 DP
FENTANYL CITRATE - FENTORA
N021947 003 8092832 Dec 30, 2024 DP
8119158 Dec 30, 2024 DP
